PEF

A renewal of the partnership between AIBN's Protein Expression Facility and PATH shows a shared commitment to eliminate this deadly disease

Professor Linda Lua, Director of the Protein Expression Facility housed at AIBN, is developing a new vaccine candidate for avian influenza.

Researchers at The University of Queensland are developing a vaccine to reduce the staggering level of infant mortality from rotavirus in developing countries by significantly decreasing the cost of vaccine production and logistics.

Queensland Health’s Forensic and Scientific Services is leading an innovative research collaboration with the Australian Institute for Bioengineering and Nanotechnology at The University of Queensland to develop an improved diagnostic test to detect Zika virus.